JP2010520242A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010520242A5 JP2010520242A5 JP2009552095A JP2009552095A JP2010520242A5 JP 2010520242 A5 JP2010520242 A5 JP 2010520242A5 JP 2009552095 A JP2009552095 A JP 2009552095A JP 2009552095 A JP2009552095 A JP 2009552095A JP 2010520242 A5 JP2010520242 A5 JP 2010520242A5
- Authority
- JP
- Japan
- Prior art keywords
- carbon atoms
- group
- formula
- branched
- saturated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004432 carbon atom Chemical group C* 0.000 claims 13
- 239000000203 mixture Substances 0.000 claims 12
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 125000003342 alkenyl group Chemical group 0.000 claims 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 6
- 229920006395 saturated elastomer Polymers 0.000 claims 6
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims 6
- 239000000126 substance Substances 0.000 claims 5
- 239000002537 cosmetic Substances 0.000 claims 3
- 230000000699 topical effect Effects 0.000 claims 3
- 208000012641 Pigmentation disease Diseases 0.000 claims 2
- 230000032683 aging Effects 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- -1 methyl- Chemical group 0.000 claims 2
- 206010040829 Skin discolouration Diseases 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 208000000069 hyperpigmentation Diseases 0.000 claims 1
- 230000003810 hyperpigmentation Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 230000003061 melanogenesis Effects 0.000 claims 1
- 230000019612 pigmentation Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000037075 skin appearance Effects 0.000 claims 1
- 230000002087 whitening effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07004524A EP1967176A1 (en) | 2007-03-06 | 2007-03-06 | Use of derivatives of 4-Hydroxyphenoxy acetic acid |
| EP07004524.0 | 2007-03-06 | ||
| PCT/EP2008/001491 WO2008107092A2 (en) | 2007-03-06 | 2008-02-26 | Use of derivatives of 4-hydroxyphenoxy acetic acid |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010520242A JP2010520242A (ja) | 2010-06-10 |
| JP2010520242A5 true JP2010520242A5 (enExample) | 2011-04-21 |
| JP5479113B2 JP5479113B2 (ja) | 2014-04-23 |
Family
ID=38335654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009552095A Expired - Fee Related JP5479113B2 (ja) | 2007-03-06 | 2008-02-26 | ４−ヒドロキシフェノキシ酢酸の誘導体の使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8247447B2 (enExample) |
| EP (2) | EP1967176A1 (enExample) |
| JP (1) | JP5479113B2 (enExample) |
| KR (1) | KR101517630B1 (enExample) |
| ES (1) | ES2436289T3 (enExample) |
| WO (1) | WO2008107092A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102552053A (zh) * | 2010-12-17 | 2012-07-11 | 考格尼斯知识产权管理有限责任公司 | 苯氧基取代的α-羟基羧酸的用途 |
| FR3006587B1 (fr) * | 2013-06-10 | 2016-05-27 | Oreal | Composition pour corriger les dyschromies cutanees et ameliorer l'homogeneite du teint |
| FR3007971B1 (fr) * | 2013-07-02 | 2016-07-15 | Oreal | Utilisation de derives de l'acide 4-hydroxyphenoxy-acetique en tant qu'agents antioxydants et/ou antiradicalaires |
| FR3007970B1 (fr) * | 2013-07-02 | 2016-08-12 | Oreal | Utilisation de derives de l'acide 4-hydroxyphenoxy-acetique en tant qu'agents apaisants |
| FR3009957B1 (fr) * | 2013-08-30 | 2018-06-29 | Oreal | Composition cosmetique comprenant un melange de polymeres sulfonique et acrylique |
| DE102015216608A1 (de) * | 2015-08-31 | 2017-03-02 | Henkel Ag & Co. Kgaa | Kosmetische Zusammensetzungen zur Hautaufhellung |
| DE102015219713A1 (de) * | 2015-10-12 | 2017-04-13 | Henkel Ag & Co. Kgaa | Kosmetische Zusammensetzung zur Hautaufhellung |
| WO2019241663A1 (en) * | 2018-06-15 | 2019-12-19 | Afecta Pharmaceuticals, Inc. | Ccl5 inhibitors |
| EP4035651B1 (en) | 2021-01-11 | 2024-11-27 | Mesoestetic Pharma Group, S.L. | Depigmenting dermopharmaceutical or cosmetic composition and use thereof |
| EP4223740A1 (en) | 2021-04-01 | 2023-08-09 | Mesoestetic Pharma Group, S.L. | Tyrosinase-inhibiting molecules and dermopharmaceutical composition that includes them |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2383662A1 (fr) * | 1977-03-15 | 1978-10-13 | Cassenne Lab Sa | Nouvelles compositions a usage cosmetique |
| JPH07121854B2 (ja) * | 1987-03-31 | 1995-12-25 | 株式会社資生堂 | 皮膚外用剤 |
| US4908476A (en) | 1988-03-21 | 1990-03-13 | Hoechst Celanese Corporation | Synthesis of 2-(4-hydroxyphenoxy)alkanoic acids |
| JPH0782588A (ja) * | 1993-09-14 | 1995-03-28 | Sanei Gen F F I Inc | 香気放出調整法 |
| JP2001354511A (ja) * | 2000-06-12 | 2001-12-25 | Shiseido Co Ltd | 美白剤およびこれを配合した皮膚外用剤 |
-
2007
- 2007-03-06 EP EP07004524A patent/EP1967176A1/en not_active Withdrawn
-
2008
- 2008-02-26 EP EP08716033.9A patent/EP2117498B1/en active Active
- 2008-02-26 KR KR1020097018424A patent/KR101517630B1/ko active Active
- 2008-02-26 US US12/530,342 patent/US8247447B2/en active Active
- 2008-02-26 JP JP2009552095A patent/JP5479113B2/ja not_active Expired - Fee Related
- 2008-02-26 ES ES08716033T patent/ES2436289T3/es active Active
- 2008-02-26 WO PCT/EP2008/001491 patent/WO2008107092A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010520242A5 (enExample) | ||
| JP2010520243A5 (enExample) | ||
| AR047972A1 (es) | Derivado de bencimidazol, proceso de obtencion y composiciones farmaceuticas. | |
| RU2014129611A (ru) | Применение производных циклогексанола в качестве антимикробных активных соединений | |
| RU2014147075A (ru) | Применение производных дициклогексилметанола с антимикробными свойствами | |
| JP2008517030A5 (enExample) | ||
| RU2007119380A (ru) | Косметические продукты, предназначенные для ухода за собой, включающие соли дигидроксипропилтри (c1-c3алкил) аммония | |
| ATE540667T1 (de) | Verbindungen mit kühlender wirkung | |
| EA201001669A1 (ru) | Замещенные пиримидин-5-карбоксамиды 281 | |
| MX2009008439A (es) | Nuevos inhibidores de la replicacion del virus de hepatitis c. | |
| MX2009006695A (es) | P-mentan-3-carboxamida sustituida con nitrogeno y sus usos. | |
| JP2008512362A5 (enExample) | ||
| BR112013026802A2 (pt) | estabilidade de peróxido melhorada em composições de tratamento oral | |
| JP2010531815A5 (enExample) | ||
| WO2008107137A3 (en) | Compositions comprising a physiological coolant | |
| AR060196A1 (es) | Agentes, composiciones y metodos para el aclaramiento de la piel | |
| WO2010066931A4 (es) | Alfa-derivados de ácidos grasos cis-monoinsaturados para ser usados como medicamento | |
| EP1739132A3 (en) | Cosmetic or pharmaceutical compositions comprising modified polyorganosiloxanes | |
| RU2012150501A (ru) | Противораковые стероидные лактоны, ненасыщенные в положении 7(8) | |
| JP2011503129A5 (enExample) | ||
| JP2013536164A5 (enExample) | ||
| JP2013525342A5 (enExample) | ||
| ZA200907956B (en) | Novel carbamoyloxy arylalkanoyl arylpiperazine compound,pharmaceutical compositions comprising the compound and method for treating pain,anxiety and depression by administering the compound | |
| MXPA06013503A (es) | Uso de compuestos de kaureno en la manufactura de medicamentos. | |
| JP2005539099A5 (enExample) |